Pemphigus Completed Phase 2 Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0001806 (Pemphigus)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00656656Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab for PemphigusTreatment